Experienced, team-based care for complex conditions
Finding a team with expertise in caring for patients with tumors at the skull base — including pituitary tumors, sinus cancer, meningioma and acoustic neuroma — can be difficult. Not only are many of these tumors rare, they pose a treatment challenge given their close proximity to the brain, eyes and major blood vessels.
To meet the challenge, the Rush Center for Skull Base and Pituitary Surgery brings together experts from more than 10 specialties to provide team-based, personalized care for patients with these tumors and other skull base disorders. Over the years, our doctors have cared for a large volume of patients with these conditions, and they are extremely adept at treating the full range of skull base disorders.
A multidisciplinary approach
Our multidisciplinary team, which includes the following specialists, meets regularly to discuss each patient and develop individualized plans for the best possible care:
Excellence in skull base and pituitary tumor care
We personalize care by bringing together specialists to meet each patient’s unique needs. By working together and sharing information, we provide optimal treatment and strive to lessen the burden of scheduling multiple appointments. If you need to see more than one specialist, we coordinate care so you can meet with all your doctors the same day.
Experience that matters
We are among a handful of programs that have in-depth experience with these rare tumors. In fact, only about 5 percent of U.S. hospitals evaluate and treat as many patients with pituitary and skull base tumors as we do here at Rush. Because of our expertise, we are able to handle even the most complex cases.
We bring the latest advances in technology to our patients. This includes the use of intraoperative CT and surgical navigation, which give surgeons the power to visualize the tumor in real-time during the procedure. This technology not only promotes safety, it helps to ensure that surgeons can completely remove the tumor.
Advancing care through research
Our doctors are also research leaders who continually seek to improve the delivery of care and patient outcomes at Rush and around the globe. We have collectively published more than 300 articles on a wide range of topics related to pituitary and skull base tumor surgery, including quality of life after skull base surgery.
Our doctors are partnering with Tempus, a biotechnology company, to gain a better understanding of the genetics of cancerous tumors and which treatment approaches specific tumors will respond to. The genetic analysis provided by Tempus is especially useful for patients who have run out of treatment options, and those with rare cancers, such as skull base tumors and salivary gland cancers.